Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension

• Published in: Journal of hypertension Vol. 15; no. 1; pp. 79 - 86
• Main Authors: Redon, Josep, Miralles, Amparo, Pascual, Jose M, Baldó, Emilio, Robles, Rafael Garcia, Carmena, Rafael
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott-Raven Publishers 01-01-1997; Lippincott Williams & Wilkins
• Subjects: Adult; Albuminuria - blood; Albuminuria - complications; Albuminuria - urine; Arterial hypertension. Arterial hypotension; Biological and medical sciences; Biomarkers; Blood and lymphatic vessels; Blood Glucose - metabolism; Blood Pressure; Cardiology. Vascular system; Cardiovascular Diseases - etiology; Case-Control Studies; Clinical manifestations. Epidemiology. Investigative techniques. Etiology; Female; Glucose Tolerance Test; Humans; Hyperinsulinism - blood; Hyperinsulinism - complications; Hyperinsulinism - urine; Hypertension - blood; Hypertension - complications; Hypertension - urine; Insulin - blood; Male; Medical sciences; Middle Aged; Risk Factors; Human; Hypertension; Target tissue resistance; Urinary system disease; Risk factor; Albumin; Cardiovascular disease; Arterial pressure; Insulin; Microalbuminuria; Proteinuria
• ISSN: 0263-6352; 1473-5598
• DOI: 10.1097/00004872-199715010-00008

OBJECTIVETo analyze the relationship between insulinemia and urinary albumin excretion in a group of nonobese, young adult hypertensive patients, who had never been treated with antihypertensive drugs.
PATIENTS AND METHODSForty-nine patients who fulfilled the inclusion criteria were included. Twenty-four-hour ambulatory blood pressure monitorings, urinary albumin excretion (UAE) measurements, and an oral glucose- tolerance test measuring glucose and insulin, were performed, and left ventricular mass was measured by echocardiography. Hypertensive patients were classified as normoalbuminuric when their UAE was < 30 mg/24 h (40 patients; mean UAE 13.4 ± 7.0 mg/24 h), and as microalbuminuric when their UAE was 30–300 mg/24 h (nine patients; mean UAE 90.5 ± 86.6 mg/24 h).
RESULTSIn comparison with that of the normoalbuminuric group, the fasting plasma glucose concentration for the microalbuminuric group was only slightly higher (100 ± 9 versus 95 ± 8 mg/dl, NS). In contrast, the fasting insulin concentration in the microalbuminuric group was significantly higher than that observed in the normoalbuminuric group (25.2 ± 6.7 versus 16.6 ± 5.2 µU/ml, P < 0.0001). During the oral glucose-tolerance test, the area under the curve (AUC) for glucose (317 ± 41 versus 253 ± 53 mg/dl x 2/h, P < 0.001) and the AUC for insulin (253 ± 171 versus 124 ± 43 µU/ml x 2/h, P < 0.001) were significantly higher in the microalbuminuric group than were those AUC observed in the normoalbuminuric group. After adjustments for age, sex, body mass index and average 24 h ambulatory mean blood pressure were made, the fasting insulin level was associated independently with an increase in UAE in a multiple regression model with base 10 logarithm of the UAE as the dependent variable. Variations in fasting insulin level alone accounted for 33% of the UAE variance. In contrast, the 24 h ambulatory mean blood pressure, rather than the insulin level, was the strongest predictor of the left ventricular mass index.
CONCLUSIONSMild hypertensive patients with microalbuminuria were hyperinsulinemic in the absence of obesity, and their insulin level was the main determinant of microalbuminuria in these patients. Microalbuminuria in essential hypertension seems to identify patients with a cluster of cardiovascular risk factors and a bad risk profile. Thus, assessment of microalbuminuria may be useful in the stratification of risk in essential hypertension.